News

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has CVS Health (CVS) been one of those stocks this year? Let's

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop

Investors interested in Finance stocks should always be looking to find the best-performing companies in the group. Is JPMorgan Chase & Co. (JPM) one of those stocks right now? A quick glance at the

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop

The Computer and Technology group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is ASML (ASML) one of those stocks right now? A

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

Featuring daily updates

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With

For those looking to find strong Retail-Wholesale stocks, it is prudent to search for companies in the group that are outperforming their peers. Casey's General Stores (CASY) is a stock that can

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With

For those looking to find strong Consumer Discretionary stocks, it is prudent to search for companies in the group that are outperforming their peers. Electronic Arts (EA) is a stock that can

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop

Veracyte (VCYT) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, VCYT crossed above the 20-day moving average, suggesting a

KLA (KLAC) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, KLAC broke through the 20-day moving average, which suggests a

After reaching an important support level, IBM (IBM) could be a good stock pick from a technical perspective. IBM surpassed resistance at the 20-day moving average, suggesting a short-term bullish

From a technical perspective, Westinghouse Air Brake Technologies (WAB) is looking like an interesting pick, as it just reached a key level of support. WAB recently overtook the 20-day moving

Tvardi Therapeutics (TVRD) has been on a downward spiral lately with significant selling pressure. After declining 83% over the past four weeks, the stock looks well positioned for a trend reversal

Eli Lilly LLY is a dominant player in the cardiometabolic space, all thanks to the encouraging uptake for its blockbuster GLP-1 drugs — Mounjaro (for type II diabetes [T2D]) and Zepbound (for

Commerce Bancshares (CBSH) reported $440.97 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 4.7%. EPS of $1.06 for the same period compares to

For the quarter ended September 2025, Snap-On (SNA) reported revenue of $1.19 billion, up 3.8% over the same period last year. EPS came in at $4.71, compared to $4.70 in the year-ago quarter.

The

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm